Antoman, Cristin A.
HRN: 24-69-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2024
CEFUROXIME 500MG (TAB)
03/28/2024
04/04/2024
PO
500mg
BID X 7 Days
S/P Primary CS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes